These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 26481440)

  • 21. A Review of Recent Research on the Role of MicroRNAs in Renal Cancer.
    Yang L; Zou X; Zou J; Zhang G
    Med Sci Monit; 2021 May; 27():e930639. PubMed ID: 33963171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oncogenic miR-663a is associated with cellular function and poor prognosis in renal cell carcinoma.
    Zhou L; Pan X; Li Z; Chen P; Quan J; Lin C; Lai Y; Xu J; Xu W; Guan X; Li H; Gui Y; Lai Y
    Biomed Pharmacother; 2018 Sep; 105():1155-1163. PubMed ID: 30021352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of the collagen cross-linking enzymes LOXL2 and PLOD2 by tumor-suppressive microRNA-26a/b in renal cell carcinoma.
    Kurozumi A; Kato M; Goto Y; Matsushita R; Nishikawa R; Okato A; Fukumoto I; Ichikawa T; Seki N
    Int J Oncol; 2016 May; 48(5):1837-46. PubMed ID: 26983694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
    Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
    J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
    Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
    Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNAs: exploring a new dimension in the pathogenesis of kidney cancer.
    White NM; Yousef GM
    BMC Med; 2010 Oct; 8():65. PubMed ID: 20964839
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upregulated microRNA-16 as an oncogene in renal cell carcinoma.
    Chen D; Li Y; Yu Z; Su Z; Yu W; Li Y; Yang S; Gui Y; Ni L; Lai Y
    Mol Med Rep; 2015 Jul; 12(1):1399-404. PubMed ID: 25815587
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNAs in Renal Cell Carcinoma.
    Sellitti DF; Doi SQ
    Microrna; 2015; 4(1):26-35. PubMed ID: 26165467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma.
    Fedorko M; Juracek J; Stanik M; Svoboda M; Poprach A; Buchler T; Pacik D; Dolezel J; Slaby O
    Biochem Med (Zagreb); 2017 Jun; 27(2):411-417. PubMed ID: 28694731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis.
    Tang K; Xu H
    Sci Rep; 2015 May; 5():10272. PubMed ID: 25974855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNAs in renal cell carcinoma: a systematic review of clinical implications (Review).
    Li M; Wang Y; Song Y; Bu R; Yin B; Fei X; Guo Q; Wu B
    Oncol Rep; 2015 Apr; 33(4):1571-8. PubMed ID: 25682771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Urinary-derived extracellular vesicle microRNAs as non-invasive diagnostic biomarkers for early-stage renal cell carcinoma.
    Zhang Y; Zhu YY; Chen Y; Zhang L; Wang R; Ding X; Zhang H; Zhang CY; Zhang C; Gu WJ; Wang C; Wang JJ
    Clin Chim Acta; 2024 Jan; 552():117672. PubMed ID: 37995985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miRNA profiling in serum and tissue samples to assess noninvasive biomarkers for NSCLC clinical outcome.
    Petriella D; De Summa S; Lacalamita R; Galetta D; Catino A; Logroscino AF; Palumbo O; Carella M; Zito FA; Simone G; Tommasi S
    Tumour Biol; 2016 Apr; 37(4):5503-13. PubMed ID: 26566629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-126 inhibits tumor cell invasion and metastasis by downregulating ROCK1 in renal cell carcinoma.
    Zhang GM; Luo L; Ding XM; Dong DH; Li B; Ma XC; Sun LJ
    Mol Med Rep; 2016 Jun; 13(6):5029-2036. PubMed ID: 27108693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Key miRNAs and target genes played roles in the development of clear cell renal cell carcinoma.
    Liu J; Liu B; Guo Y; Chen Z; Sun W; Gao W; Wu H; Wang Y
    Cancer Biomark; 2018; 23(2):279-290. PubMed ID: 30198869
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of miR‑130b as an oncogene in renal cell carcinoma.
    Li Y; Chen D; Li Y; Jin L; Liu J; Su Z; Qi Z; Shi M; Jiang Z; Gui Y; Yang S; Mao X; Lai Y
    Mol Med Rep; 2016 Feb; 13(2):1902-8. PubMed ID: 26717956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel prognostic biomarkers in renal cell carcinoma.
    Zou Y; Lu Q; Yao Q; Dong D; Chen B
    Aging (Albany NY); 2020 Nov; 12(24):25304-25318. PubMed ID: 33234734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma.
    Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L
    Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
    Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.